founders in the news – en – old

August 2022 – Eternygen published new paper on SLC13A5 inhibitors titled: “A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis in Mice with Diet-Induced Obesity”

Eternygen published new paper on SLC13A5 inhibitors titled: “A Novel and Cross-Species Active Mammalian INDY (NaCT) Inhibitor Ameliorates Hepatic Steatosis ...
Read More

November 2021 – Prof. Birkenfeld featured in german TV ZDF Series “Auf der Suche nach dem ewigen Leben”

Eternygen Co-Founder Andreas Birkenfeld is featured in the German TV ZDF Series "Auf der Suche nach dem ewigen Leben" and ...
Read More

Prof. Birkenfeld publishes new review on Transporters as Drug Targets titled „Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.”

Prof. Birkenfeld publishes new review on Transporters as Drug Targets titled „Solute Carrier Transporters as Potential Targets for the Treatment ...
Read More

Prof. Birkenfeld publishes new review on NAFLD

Prof. Birkenfeld publishes new review on NAFLD (Link to Paper) ...
Read More

Prof. Birkenfeld in Sächsische Zeitung

Prof. Birkenfeld in Sächsische Zeitung Prof. Birkenfeld in Sächsische Zeitung with the topic "How your lifestyle advances diabetes". (Article in ...
Read More

Prof. Birkenfeld publishes new INDY (I’m Not Dead Yet) review

Prof. Birkenfeld publishes new INDY (I'm Not Dead Yet) review Prof. Birkenfeld publishes new INDY (I'm Not Dead Yet) review ...
Read More

Prof. Birkenfeld visiting expert at MDR Sachsen radio

Prof. Birkenfeld visiting expert at MDR Sachsen radio Prof. Birkenfeld visiting expert at MDR Sachsen radio talking about cholesterol (in German) ...
Read More

Prof. Birkenfeld in expert discussion with MDR1 radio

Prof. Birkenfeld in expert discussion with MDR1 radio Discussion about "Sugar as a drug" (in German) ...
Read More